Skip to content

Protagonist Therapeutics PTGX Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

EAT
Brinker InternationalEAT
$300K-98.7%
Schneider National logo
Schneider NationalSNDR
$37.7M+109%
ACM Research logo
ACM ResearchACMR
$13.18M-43.7%
US Foods logo
US FoodsUSFD
$64M+56.1%
Plexus logo
PlexusPLXS
$2.55M-65.7%
PayPal Holdings, Inc. logo
PayPal Holdings, Inc.PYPL
$2.25M-35.7%

Other financials

Income statement

See full
Revenue$56.4M+99.0%
Operating income-$3.6M+81.1%
Net income$3.8M+132%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$193.7M+38.7%
Total debt$9.8M-13.9%
Total equity$655.5M-4.9%
Total assets$697.5M-6.0%

Cash flow

See full
Operating cash flow-$48.9M-139%
CapEx$215.0K-60.6%
Free cash flow-$49.2M-139%

Valuation

See full
Market cap$7.26B+127%
Enterprise value$7.07B+130%
P/S98×+82.6×

Profitability

See full
Operating margin-192.4%-205pp
Net margin-154.9%-182pp
FCF margin-12,264.3%-12,527pp

Returns & leverage

See full
Return on equity-17.1%-26.1pp
Debt / equity0.0×
Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Protagonist Therapeutics's capital investments accrued but not yet paid?
Protagonist Therapeutics (PTGX) reported capital investments accrued but not yet paid of $110K in Q1 2026.
How has Protagonist Therapeutics's capital investments accrued but not yet paid changed year-over-year?
Protagonist Therapeutics's capital investments accrued but not yet paid increased by 233.3% year-over-year, from $33K to $110K.